<h3>涨幅榜</h3>
<ul>
<li><strong>Cue Biopharma</strong> (NASDAQ: CUE) 的股票在周五的常规交易中上涨了 69.9%，至 $0.5。该公司的市值为 2860 万美元。</li>
<li><strong>Plus Therapeutics</strong> (NASDAQ: PSTV) 的股票上涨了 32.14%，至 $5.18。该公司的市值为 2680 万美元。</li>
<li><strong>Tempest Therapeutics</strong> (NASDAQ: TPST) 的股票上涨了 30.37%，至 $2.06。该公司的市值为 2260 万美元。</li>
<li><strong>Zentalis Pharmaceuticals</strong> (NASDAQ: ZNTL) 的股票上涨了 29.61%，至 $5.73。其流通股的市场价值为 3.135 亿美元。</li>
<li><strong>Treace Medical Concepts</strong> (NASDAQ: TMCI) 的股票上涨了 20.58%，至 $1.84。其流通股的市场价值为 9740 万美元。</li>
<li><strong>Organon</strong> (NYSE: OGN) 的股票上涨了 20.47%，至 $8.32。其流通股的市场价值为 17 亿美元。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>CDT Equity</strong> (NASDAQ: CDT) 的股票在周五的常规交易中下跌了 23.8%，至 $4.49。其流通股的市场价值为 2780 万美元。</li>
<li><strong>Replimune Group</strong> (NASDAQ: REPL) 的股票下跌了 19.46%，至 $4.76。其流通股的市场价值为 4.636 亿美元。</li>
<li><strong>Harvard Bioscience</strong> (NASDAQ: HBIO) 的股票下跌了 16.39%，至 $4.49。该公司的市值为 2400 万美元。</li>
<li><strong>Insight Molecular</strong> (NASDAQ: IMDX) 的股票下跌了 16.2%，至 $2.67。该公司的市值为 1.022 亿美元。</li>
<li><strong>Profusa</strong> (NASDAQ: PFSA) 的股票下跌了 16.09%，至 $0.88。该公司的市值为 140 万美元。</li>
<li><strong>Virax Biolabs Group</strong> (NASDAQ: VRAX) 的股票下跌了 15.66%，至 $0.11。其流通股的市场价值为 100 万美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>

REPL

TPST

标普生物技术 ETF - SPDR

<p>在周五的交易中，Cue Biopharma 录得显著上涨，涨幅达到 69.9%，股价达到 0.5 美元，而 Plus Therapeutics 和 Tempest Therapeutics 分别上涨了 32.14% 和 30.37%。其他值得注意的涨幅股票包括 Zentalis Pharmaceuticals 和 Treace Medical Concepts。相反，CDT Equity 录得最大跌幅，下降 23.8%，紧随其后的是 Replimune Group 和 Harvard Bioscience，分别下跌 19.46% 和 16.39%。总体而言，医疗行业表现参差不齐，股票价格波动显著</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>涨幅榜</h3>
</div><ul>
<li><strong>Cue Biopharma</strong> (NASDAQ: CUE) shares increased by 69.9% to $0.5 during Friday's regular session. The company's market cap stands at $28.6 million.</li>
<li><strong>Plus Therapeutics</strong> (NASDAQ: PSTV) shares moved upwards by 32.14% to $5.18. The company's market cap stands at $26.8 million.</li>
<li><strong>Tempest Therapeutics</strong> (NASDAQ: TPST) shares rose 30.37% to $2.06. The company's market cap stands at $22.6 million.</li>
<li><strong>Zentalis Pharmaceuticals</strong> (NASDAQ: ZNTL) stock rose 29.61% to $5.73. The market value of their outstanding shares is at $313.5 million.</li>
<li><strong>Treace Medical Concepts</strong> (NASDAQ: TMCI) shares moved upwards by 20.58% to $1.84. The market value of their outstanding shares is at $97.4 million.</li>
<li><strong>Organon</strong> (NYSE: OGN) stock moved upwards by 20.47% to $8.32. The market value of their outstanding shares is at $1.7 billion.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Cue Biopharma</strong> (NASDAQ: CUE) 的股票在周五的常规交易中上涨了 69.9%，至 $0.5。该公司的市值为 2860 万美元。</li>
<li><strong>Plus Therapeutics</strong> (NASDAQ: PSTV) 的股票上涨了 32.14%，至 $5.18。该公司的市值为 2680 万美元。</li>
<li><strong>Tempest Therapeutics</strong> (NASDAQ: TPST) 的股票上涨了 30.37%，至 $2.06。该公司的市值为 2260 万美元。</li>
<li><strong>Zentalis Pharmaceuticals</strong> (NASDAQ: ZNTL) 的股票上涨了 29.61%，至 $5.73。其流通股的市场价值为 3.135 亿美元。</li>
<li><strong>Treace Medical Concepts</strong> (NASDAQ: TMCI) 的股票上涨了 20.58%，至 $1.84。其流通股的市场价值为 9740 万美元。</li>
<li><strong>Organon</strong> (NYSE: OGN) 的股票上涨了 20.47%，至 $8.32。其流通股的市场价值为 17 亿美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>CDT Equity</strong> (NASDAQ: CDT) shares declined by 23.8% to $4.49 during Friday's regular session. The market value of their outstanding shares is at $27.8 million.</li>
<li><strong>Replimune Group</strong> (NASDAQ: REPL) stock declined by 19.46% to $4.76. The market value of their outstanding shares is at $463.6 million.</li>
<li><strong>Harvard Bioscience</strong> (NASDAQ: HBIO) stock fell 16.39% to $4.49. The company's market cap stands at $24.0 million.</li>
<li><strong>Insight Molecular</strong> (NASDAQ: IMDX) stock declined by 16.2% to $2.67. The company's market cap stands at $102.2 million.</li>
<li><strong>Profusa</strong> (NASDAQ: PFSA) shares decreased by 16.09% to $0.88. The company's market cap stands at $1.4 million.</li>
<li><strong>Virax Biolabs Group</strong> (NASDAQ: VRAX) shares decreased by 15.66% to $0.11. The market value of their outstanding shares is at $1.0 million.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>CDT Equity</strong> (NASDAQ: CDT) 的股票在周五的常规交易中下跌了 23.8%，至 $4.49。其流通股的市场价值为 2780 万美元。</li>
<li><strong>Replimune Group</strong> (NASDAQ: REPL) 的股票下跌了 19.46%，至 $4.76。其流通股的市场价值为 4.636 亿美元。</li>
<li><strong>Harvard Bioscience</strong> (NASDAQ: HBIO) 的股票下跌了 16.39%，至 $4.49。该公司的市值为 2400 万美元。</li>
<li><strong>Insight Molecular</strong> (NASDAQ: IMDX) 的股票下跌了 16.2%，至 $2.67。该公司的市值为 1.022 亿美元。</li>
<li><strong>Profusa</strong> (NASDAQ: PFSA) 的股票下跌了 16.09%，至 $0.88。该公司的市值为 140 万美元。</li>
<li><strong>Virax Biolabs Group</strong> (NASDAQ: VRAX) 的股票下跌了 15.66%，至 $0.11。其流通股的市场价值为 100 万美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>
</div>

12 只医疗保健股票在周五盘中交易中出现波动